Metabolic engineering is the core discipline behind using living cells as factories. Every cell runs thousands of interconnected chemical reactions (its metabolism), converting nutrients into energy and building blocks. Metabolic engineers modify these pathways — adding new enzyme-coding genes, deleting competing pathways, and tuning gene expression levels — to redirect cellular resources toward producing a target molecule. The goal is to turn a microorganism into an efficient, scalable production platform for chemicals, fuels, pharmaceuticals, or materials.
The field has delivered commercially significant products. Engineered yeast and bacteria now produce artemisinic acid (precursor to the antimalarial artemisinin), 1,3-propanediol (a polymer building block produced by DuPont/Tate & Lyle), farnesene (a versatile hydrocarbon produced by Amyris), and countless flavors, fragrances, and nutritional ingredients. Companies like Ginkgo Bioworks, Zymergen (acquired by Ginkgo), and LanzaTech are building platforms for rapid metabolic engineering across diverse target molecules.
Modern metabolic engineering increasingly relies on computational tools — genome-scale metabolic models, flux balance analysis, and machine learning — to predict which genetic modifications will maximize production. The design-build-test-learn cycle has been dramatically accelerated by automated biofoundries and high-throughput screening. Key challenges remain in scaling production from laboratory flasks to industrial fermenters, where cell behavior can change dramatically, and in achieving cost parity with petrochemical production routes for commodity chemicals. For deeper coverage, see SynBioIntel.